US$ 20.65
comparing glp-1 agonists Receptor Glucagon-Like Peptide 1 Receptor Agonists
Description
Serious side effects are rare but may include severe allergic reactions (anaphylaxis) or inflammation of the pancreas (pancreatitis)

Recombinant AAV was harvested by five cycles of freezethawing of the resuspended pellet
Mechanisms of muscle loss associated with GLP-1RAs treatment Preservation of skeletal muscle is critical for metabolic health, physical function and long-term outcomes, making the study of mechanisms underlying muscle loss during GLP-1RA therapy clinically relevant

Block ML, Hong J-S

As per FMI estimates, these two leaders collectively control a significant majority of market value, particularly in premium diabetes and obesity segments

North America dominated the GLP-1 receptor agonist market with a market share of 61.23% in 2025
